Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Development and validation of a quality of life scale for pediatric mastocytosis.

Created on 19 Jul 2026

Authors

Aslı Berivan Topçak, Ece Tüsüz Önata, Şeyma Genç, Sefika Ilknur Kökcü Karadag, Nilay Çalışkan, Güler Yıldırım, Hamit Boloğur, Hilal Güngör, Merve Karaca Şahin, Muhammed Fatih Erbay, Hasan Tunç Şarman, Özlem Terzi, Emek Kocatürk, Frank Siebenhaar, Öner Özdemir, Deniz Özçeker

Published in

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology. Jul 18, 2026. Epub Jul 18, 2026.

Abstract

Mastocytosis imposes a considerable burden on patients' quality of life. While validated QoL instruments are available for adults with systemic mastocytosis, no disease-specific quality-of-life measure has yet been developed for pediatric populations.
This study aimed to develop and validate two disease-specific quality of life instruments-the Pediatric Mastocytosis Quality of Life (PedMQLS) and the Pediatric Mastocytosis Quality of Life-Parent (PedParentMQLS) scales-for use in pediatric mastocytosis.
A total of 51 children and their parents were recruited from two specialized tertiary centers in Turkey. Scale items were generated based on expert opinion and literature review. Content validity was evaluated using the Davis method, and construct validity was assessed through exploratory factor analysis (EFA). Internal consistency was measured using Cronbach's alpha, and convergent validity was examined by correlating results with established dermatology-specific quality of life instruments.
Both scales consisted of 14 items and revealed a two-factor structure covering social and emotional domains. Pediatric Mastocytosis Quality of Life-Parent Scale showed high internal consistency (α = 0.909), while the Pediatric Mastocytosis Quality of Life Scale demonstrated acceptable reliability (α = 0.785). Significant correlations with comparable instruments supported the scales' convergent validity.
These newly developed scales are the first validated quality of life instruments specific for pediatric mastocytosis. This study is preliminary; validation through multicenter studies with larger sample.

PMID:
42471699
Bibliographic data and abstract were imported from PubMed on 19 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement